Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does the BHMT pathway use betaine derived from choline to remethylate homocysteine independently of folate?

The BHMT pathway remethylates homocysteine using betaine derived from choline and becomes more relied upon when folate is low.

SupportedJune 19, 202612 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The betaine-homocysteine methyltransferase pathway uses betaine (derived from choline) to remethylate homocysteine independent of folate, so greater reliance on choline/betaine becomes important when folate is low.

laying out figure…
All 9 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a folate-independent remethylation route in liver and kidney where choline is oxidized to betaine, which BHMT uses to convert homocysteine back to methionine. The mechanism graph frames BHMT as a compensatory pathway operating in parallel to the folate (5-MTHF) pathway and indicates that low folate status increases reliance on choline/betaine-mediated remethylation.

Verified conclusion

Homocysteine regulation is a critical metabolic process that relies on two distinct but complementary remethylation pathways. While the folate-dependent pathway is ubiquitous, the liver and kidneys utilize a specialized alternative to maintain methyl balance when folate levels are insufficient.

Mechanistic basis of BHMT

The betaine-homocysteine methyltransferase (BHMT) pathway functions as a zinc-dependent metabolic route primarily located in the liver and kidneys. Unlike the methionine synthase pathway, which requires 5-methyltetrahydrofolate (5-MTHF) and vitamin B12, the BHMT pathway uses betaine—a direct oxidation product of choline—as its methyl donor.

  • Path independence: BHMT operates independently of the folate cycle, allowing it to provide up to 50% of hepatic homocysteine remethylation.
  • Substrate specificity: In the absence of BHMT activity, research shows hepatic betaine concentrations can increase over 20-fold, confirming betaine is the essential and specific substrate for this folate-free route.

Clinical evidence and folate status

The metabolic importance of the BHMT pathway is inversely related to folate availability. When folate levels are low, the body increases its reliance on choline and betaine to prevent the accumulation of homocysteine.

  • Population data: Large-scale studies, including the Framingham Offspring Study, have demonstrated that the protective effect of high choline and betaine intake on homocysteine levels is most pronounced in individuals with the lowest folate status.
  • Genetic interactions: Individuals with MTHFR polymorphisms (which impair folate metabolism) exhibit a higher biological demand for choline. This indicates that the BHMT pathway acts as a crucial compensatory mechanism when the primary folate-dependent pathway is compromised.

Bottom line

The BHMT pathway provides a vital folate-independent mechanism for homocysteine regulation using betaine derived from choline. Reliance on this pathway is significantly heightened during folate deficiency or in individuals with genetic impairments in folate metabolism, making adequate choline and betaine intake essential for maintaining cardiovascular and metabolic health in these contexts.

References

  1. Methylation demand: a key determinant of homocysteine metabolism. — ojs.ptbioch.edu.pl ↗
  2. High homocysteine induces betaine depletion — bioscirep.org ↗
  3. Liver betaine-homocysteine S-methyltransferase activity undergoes a redox switch at the active site zinc. — pmc.ncbi.nlm.nih.gov ↗
  4. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects — pmc.ncbi.nlm.nih.gov ↗
  5. Study of the relationships of polymorphisms of the folate cycle genes with the levels of homocysteine and folic acid as risk factors of cardiovascular disorders in the post-covid period — journals.uran.ua ↗
  6. The Shuttling of Methyl Groups Between Folate and Choline Pathways — mdpi.com ↗
  7. Betaine and Folate Status as Cooperative Determinants of Plasma Homocysteine in Humans — ahajournals.org ↗
  8. Betaine: a key modulator of one-carbon metabolism and homocysteine status — degruyter.com ↗
  9. Are dietary choline and betaine intakes determinants of total homocysteine concentration? — pmc.ncbi.nlm.nih.gov ↗
  10. Deletion of Betaine-Homocysteine S-Methyltransferase in Mice Perturbs Choline and 1-Carbon Metabolism, Resulting in Fatty Liver and Hepatocellular Carcinomas* — pmc.ncbi.nlm.nih.gov ↗
  11. Plasma choline, homocysteine and vitamin status in healthy adults supplemented with krill oil: a pilot study — tandfonline.com ↗
  12. Anti‐lipogenic effect of betaine involves inhibition of homocysteine‐induced ER stress via upregulation of betaine‐homocysteine methyltransferase — faseb.onlinelibrary.wiley.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→